SCR-LIP-000507 · Claim · machine-readable JSON →

In a comparative cross-sectional study, women with lipedema (n=104) had significantly lower HR-QoL (RAND-36) than healthy controls across all eight dimensions (p<0.001), scores comparable to women with advanced cancer in several dimensions (even lower in general health), greater body image concern (BSQ, p=0.001), and higher symptom burden including depression and anxiety (ESAS, p<0.001).

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026Lipedema in Sweden – “The LISE-study”: Quality of life and body image in women with lipedema compared to healthy controls and women with cancer (2026) · consistent

Evidence (1)

Context (PECO)

Populationwomen with lipedema (n=104)
Conditionlipedema
Exposurelipedema diagnosis
Comparatorhealthy women (n=42) and women with advanced cancer (n=44)
OutcomeHR-QoL (RAND-36), body image (BSQ), symptoms incl. depression/anxiety (ESAS)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log